Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Sponsors tell committee Patient Protection Act would require in‑person exams, ban mail order for some high‑risk drugs
Summary
Sponsors said House Bill 324 would prohibit mail order sales of drugs that cause severe adverse events in more than 5% of users and require in‑person exams and follow‑ups for such drugs; proponents said the Director of Health would publish the list in consultation with insurers and state boards.
House Bill 324, labeled in testimony as the "Patient Protection Act," received its first hearing before the Ohio House Health Committee. A sponsor presented the bill as a measure to increase oversight and safety for medications with a high risk of severe adverse effects, defined in testimony as those causing death, organ failure, sepsis, infections requiring hospitalization, or hemorrhaging at a rate affecting more than 5…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
